13.08.2014

New insight into the survival and transmission strategy of malaria parasites

Malaria parasites exploit the function of the well-known epigenetic regulator HP1 to promote their survival and transmission between human hosts, a new study by the Swiss Tropical and Public Health Institute shows. Using HP1 the parasite specifically controls expression of surface antigens to escape immune responses in the infected victim. This prolongs survival of the parasite in the human blood stream and secures its transmission via mosquitoes. The study paves important avenues for new intervention strategies to prevent severe disease and malaria transmission. The study is published in Cell Host & Microbe.

Immunofluorescence images of Plasmodium falciparum gametocytes at various stages of sexual differentiation (left to right: increasing level of maturity).

 

HP1 proteins are found in most eukaryotic organisms and are important regulators of gene silencing. In short, HP1 induces heritable condensation of chromosomal regions. As a result genes located within these regions are not expressed. Importantly, since this conformation is reversible HP1-controlled genes can become activated without requiring changes in the underlying DNA sequence.

 

The team led by Till Voss at the Swiss Tropical and Public Health Institute/University of Basel in collaboration with colleagues from the Nanyang Technological University in Singapore engineered a mutant parasite in which HP1 expression can be shut down at the push of a button. The researchers observed that in HP1-depleted parasites all of the 60 so-called var genes became highly active.

 

Each var gene encodes a distinct variant of the virulence factor PfEMP1, which is displayed on the surface of the parasite-infected red blood cell. PfEMP1 is a major target of the immune system in infected humans. Individual parasites normally express only one of the 60 different var/PfEMP1 proteins, while keeping all other members silenced. By switching to another var/PfEMP1 variant the parasite is able to escape existing immune responses raised against previous variants. The new study shows that HP1 protects the PfEMP1 antigenic repertoire from being exposed to the immune system at once.

 

The new study shows that HP1 protects the PfEMP1 antigenic repertoire from being exposed to the immune system at once. “This finding is a major step forward in understanding the complex mechanisms responsible for antigenic variation,” says Till Voss from the Swiss Tropical and Public Health Institute in Basel. “Furthermore, the tools generated in our study may be relevant for future research on malaria vaccines and immunity.”

 

Lack of HP1 triggers production of malaria transmission stages

Importantly, the study also reveals that parasites lacking HP1 fail to copy their genomes and are hence unable to proliferate. “Initially, we thought all parasites in our culture dish were dead,” says Till Voss. However, it turned out that over 50% of these parasites were fully viable and differentiated into gametocytes, the sexual form of the malaria parasite. Gametocytes are the only form of the parasite capable of infecting a mosquito and therefore a prerequisite to transmit malaria between humans. “Such a high sexual conversion rate is unprecedented. Usually only around 1% of parasites undergo this switch,” the researcher explains.

 

Further experiments show that a master transcription factor triggering sexual differentiation (termed AP2-G) is expressed at much higher levels in parasites lacking HP1. Under normal conditions, HP1 silences the expression of AP2-G and thus prevents sexual conversion in most parasites.

 

“The switch from parasite proliferation to gametocyte differentiation is controlled epigenetically by a HP1-dependent mechanism,” says Till Voss. “This is really exciting. With this knowledge in hand, and with the identification of another epigenetic regulator involved in the same process (published in the same issue of Cell Host & Microbe), we are now able to specifically track the sexual conversion pathway in molecular detail.” This may pave the route for the development of new drugs preventing sexual conversion and consequently malaria transmission.

 

The study was financed by the Swiss National Science Foundation, the Singaporean National Medical Research Council, the OPO Foundation, the Rudolf Geigy Foundation and the Boehringer Ingelheim Fonds.

 

Study

Heterochromatin Protein 1 Secures Survival and Transmission of Malaria Parasites. Nicolas M. B. Brancucci, Nicole L. Bertschi, Lei Zhu, Igor Niederwieser, Wai Hoe Chin, Rahel Wampfler, Céline Freymond, Matthias Rottmann, Ingrid Felger, Zbynek Bozdech, and Till S. Voss. Cell Host & Microbe 16, 165-176. 2014

Direct Link

 

Media release on Eurekalert: http://www.eurekalert.org/pub_releases/2014-08/stap-nii081314.php

 

More information

Till Voss

 

 

 

back to list